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Studies ofthe toxic actions of2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in numerous animal models
and in human and animal cells in culture have established that the most characteristic pathologic lesions
produced by this compound result from events initiated by the interaction ofTCDD with a specific intra-
cellular receptor protein, the Ah receptor. Although most research on the interaction of TCDD with the
Ah receptor has focused on establishing involvement ofthis receptor complex in specific toxic responses,
recent application of modern cell and molecular biology techniques is yielding new insights into the
mechanism(s) ofsignal transduction. Elucidation ofthese mechanisms is essential for understanding the
molecular basis ofthe cell and species specificity which is a hallmark of TCDD toxicity. This knowledge
should provide the framework for development ofa more toxicologically relevant risk assessment model.
Introduction
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is the
extensively studied prototype for the halogenated aro-
matic compounds (HACs), a large group of environ-
mental toxicants that includes the dibenzo-p-dioxins,
dibenzofurans, biphenyls, and azo- and azoxybenzenes
(1-3). Studies in various animal models and in human
and animal cells in culture indicate that TCDD and isos-
teric HACs produce a characteristic pattern of patho-
logic lesions separable into two major categories: those
that are widely expressed such as thymic atrophy, ter-
atogenesis, and wasting; and species-specific responses
includinghepatotoxicity, edema ofthepericardium, and
hyperkeratosis and chloracne (4). Hyperkeratosis and
chloracne are responses commonly observed in humans
(5,6). Other reported clinical abnormalities include
weight loss, impaired liver function, hepatic porphyria,
general malaise, and peripheral neuropathies (7).
Suppression ofspecificT-lymphocyte functionshasbeen
reportedinindividuals whoingested PCB-contaminated
rice oil(8-10). Chlorinated dibenzofurans presentinthe
PCB mixture are the suspected immunosuppressive
agents (8-11).
Many of the actions of TCDD and related HACs on
target cells aremediated by aspecificintracellular bind-
ing protein (to be designated in this report as the Ah
receptor) (2,5). Studies carried out in inbred murine
strains have established that the Ah receptor mediates
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the TCDD-dependent induction of a battery of genes
coding for cytochrome P1-450 and other enzymes pri-
marily involved in xenobiotic metabolism (2). In epi-
thelial cells from certain target organs the Ah receptor
ispostulatedtoregulate asecond genebatteryencoding
proteins involved in the control ofcell proliferation and
differentiation (2,12,13). Genetic analysis of TCDD-
induced epidermal hyperplasia in haired and hairless
strains of inbred mice has demonstrated that this Ah
receptor-dependent response occurs only in the pres-
ence of a second regulatory gene (designated hr) (14).
Skin and Thymus Toxicity: In Vitro
Models
Several in vitro model systems have been developed
and used for study ofthe mechanisms ofTCDD toxicity
to skin (13,15-18) and thymus (19-21). Analysis ofthe
concentration-dependence and stereospecificity
requirements for toxic responses elicited by TCDD and
otherHACsinthevariousinvitromodelshasconfirmed
the involvement of the Ah receptor; however, specific
transductional events triggered by the reversible bind-
ing ofHAC agonists with the Ah receptor remain to be
elucidated. Most studies have been largely correlative
and have not investigated the molecular determinants
of toxicity. Such information is essential for providing
a mechanistic basis potentially useful for risk analysis.
This is perhaps best demonstrated by the studies cited
above in hairless mice in which it was shown that at
least two regulatory genes (Ah, the putative structural
gene locus fortheAhreceptor, and hr) arerequired for
the expression oftoxicity; i.e., the presence of the AhCOOK, GAIDO, AND GREENLEE
receptor in skin target cells is obligatory, but not suf-
ficient to elicit a toxic response in murine skin (2,14).
Skin
Cultures of normal human epidermal cells and human
squamous cell carcinoma (SCC) lines have been estab-
lished in this laboratory as models for TCDD-induced ep-
idermalhyperkeratinization (22). Treatmentofnewlycon-
fluent cultures of epidermal cells with TCDD results in
an increase in the relative proportion of more highly dif-
ferentiated cells as judged by histologic examination, de-
creases in the number of basal proliferating cells, and
increases in the number ofboth envelope competent cells
and cells with highly cross-linked cornified envelopes (23).
This response observed in vitro appears to be analogous
to the epidermal hyperkeratinization reported in both an-
imal models (14) and in humans exposed to TCDD-con-
taminated 2,3,5-trichlorophenol (24).
Potential biochemical mechanisms for this TCDD-in-
duced hyperkeratinization response have been studied
in human SCC lines that display predominantly either
enhanced differentiation (line SCC-12F) or altered pro-
liferation (line SCC-9) in the presence of TCDD (13).
Evidence obtained from these models indicates that
TCDD-induced changes in growth and differentiation
result from a complex interaction of the Ah receptor,
with at least three other receptor systems involved in
normal physiologic regulation of epithelial cell prolif-
eration (13).
EGF Receptor
Interaction of the Ah receptor with one of these re-
ceptor systems, the EGF receptor, has been studied in
some detail (25,26). In normal human epidermal cells it
was observed that TCDD produced a concentration-de-
pendentdecreaseinhigh-affinity EGFbinding(23). This
response was only elicited by Ah receptor ligands and
preceded detectable TCDD-dependent modulation of
terminal differentiation. Analysis carried outwith SCC-
12F cells indicated that TCDD through interaction with
its cognate receptor (the Ah receptor) produced a sus-
tained decrease in high-affinity EGF receptor binding
but had no effect on the low-affinity EGF receptor bind-
ing (25). A number of lines of evidence suggested that
modulation of EGF receptor binding was one of the
determinants ofTCDD-dependent epidermal hyperker-
atinization observed in vitro (25,26).
Based largely on the similarity between the values
for the calculated half-life (20 hr) for the reduction in
high-affinity EGF binding in TCDD-treated SCC-12F
cells (25) with the reported half-life (16 hr) for EGF
receptor turnover in the human epidermoid carcinoma
line A431 (27), it was postulated that TCDD altered the
turnoveroftheEGFreceptorinSCC-12Fcells, possibly
through suppression of the EGF receptor structural
gene (13). Recent studies in this laboratory (28), how-
ever, indicatethatTCDD treatment does notalterEGF
receptor gene transcription or processing of the EGF
receptor RNA transcript (Fig. 1). Potential posttran-
scriptional actions ofTCDD on EGF receptor turnover
have not been examined.
Actions on Thymic Epithelial Cells
Studies carried out in congenic and specific strains
of inbred mice indicate that toxic responses to TCDD
in several immune system target cells is mediated by
the Ah receptor (29-32). Genetic analysis of TCDD-
induced thymus atrophy indicates that a second regu-
latory locus is not required for the production of this
Ah receptor-dependent response (e.g., thymic atrophy
occurs in both haired and hairless C57BL/6 mice) (2).
Several lines ofevidence led totheproposalthat thymic
epithelium was the target cell for both TCDD-induced
thymus atrophy (29,30) and enhanced T-suppressor cell
activity (2,31,33). Previous studies carried out in this
laboratory (20) demonstrated that TCDD can act di-
rectly on murine thymic epithelial monolayers to sup-
press the maturation of cocultured thymocytes. It was
postulated that impaired thymocyte maturation could
lead to increased thymocyte death and the depletion of
cortical thymocytes characteristic of TCDD-induced
thymic atrophy (12).
In a subsequent investigation, the actions of TCDD
on cultures of epithelial cells established from human
thymus specimens were characterized (21). The param-
etersexaminedincludedtheinductionofthecytochrome
P1-450 monooxygenase activities, 7-ethoxycoumarin 0-
deethylase (ECOD) and7-ethoxyresorufin 0-deethylase
(EROD), and modulation of HuTE-dependent thymo-
cyte responsiveness to the mitogens concanavalin A
(Con A) and phytohemagglutinin (PHA). TCDD was
found to induce the measured cytochrome P1-450 activ-
ities and to suppress HuTE-dependent thymocyte ma-
turation. The concentration-dependence and stereo-
specificity (asjudged by the relative activities ofchlori-
nated dibenzo-p-dioxin and dibenzofuran isomers) for
both responses elicited by TCDD in HuTE cells indi-
cated involvement ofthe Ah receptor (21). Comparison
ofTCDD-dependent inductionofcytochrome P1-450 and
impaired thymocyte maturation in several strains of
HuTE cells indicated significant interstrain differences
in maximally inducible ECOD and EROD activities
(Fig. 2 and Table 1) which did not appear to directly
correlate with the measured concentration of the Ah
receptor in HuTE cytosol. In certain HuTE strains
treated with TCDD, differences in both sensitivity and
magnitude were observed for the impaired HuTE-de-
pendent thymocyte maturation (Fig. 3). Significant dif-
ferences in sensitivity for the induction ofECOD activ-
ity were not seen (Fig. 2).
These observations on the actions ofTCDD in HuTE
cells suggested that human thymus is a potential target
for TCDD and isosteric HACs. The validity of this in
vitro model system as a predictor of toxicity is sup-
ported by recent reports of altered cell-mediated im-
munity in individuals exposed to chlorinated dibenzo-
furans (11,12). Inaddition, the invivo dose ofTCDD that
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FIGURE 1. Filter hybridization analysis of total RNA from control and TCDD-treated SCC-12F cells. (A) Restriction sites of 889 bp cDNA
probe encoding the 3' end ofthe human EGF receptor gene [designated clone phEGFR-1 (41)]. (B) Left: total RNA prepared from control
and TCDD-treated (10 nM, 48 hr) cells was applied to nitrocellulose filters, hybridized to nick-translated phEGFR-1, and analyzed by
autoradiography. Lane A, no treatment; Lane B, 0.01% DMSO (control); Lane C, 10 nM TCDD. The numbers in the first column indicate
the amount ofRNA (,ug) applied to each well in the corresponding row. Right: northern analysis oftotal RNA. Lane 1, no treatment; Lane
2, 0.01% DMSO (48 hr); Lane 3, 10 nM TCDD (48 hr); Lane 4, 0.01% DMSO (72 hr); Lane 5, 10 nM TCDD (72 hr). The arrow indicates
EGF receptor mRNA (6 kb). Taken in part from Osborne et al. (28).
promises host resistance and produces thymic atrophy in
C57BL/6 mice is similar to concentrations shown to be
active in both cultured murine thymic epithelial (20) and
HuTE (21) cells. At least three conclusions relevant to
the assessment of the toxic potential of HACs can be
drawn from the studies carried out in the HuTE cell cul-
ture model system: (a) the Ah receptor mediates the bio-
chemicaland toxic actions ofTCDD on an epithelialtarget
cell population derived from human thymus; (b) HuTE
strains established from thymus samples from difference
individuals can differmarkedly in sensitivity tothe immu-
notoxic actions of TCDD; and (c) quantitation of the Ah
receptor content (or measurement of cytochrome P1450
inducibility, a widely accepted Ah receptor-mediated
it
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FIGURE 2. (A) Log dose-response curves for the induction ofECOD activity by TCDD in three strains of HuTE cells. Each point represents
the mean ± SEM of three experiments. Points without error bars have an SE less than the symbol size. (B) Fractional dose-response
curves ofthe data in (A). The mean control activity was equated to zero, the mean maximally induced activity to 1.0, and the intermediate
responses were calculated as a fraction of the maximal response. The ECQ values for the three strains are 2.0 nM (HuTE-C), 0.9 nM
(HuTE-L), and 0.8 nM (HuTE-M). From Cook et al. (21).
response) is not necessarily an accurate quantitative pre-
dictor oftoxic susceptibility.
Conclusions
A central focus ofmost studies on the mechanisms of
toxicity of HACs in various animal and cell culture
model systems has been at the level oftheAh receptor.
Receptor mediated actions occur through a specific se-
quence of events: reversible binding of the ligand (ef-
fector) to its cognate receptor (recognition); transmis-
sion ofthe binding signal into a molecular effector sys-
tem (transduction); and generation of a response (34).
Much is known implicating the Ah receptor in various
Table 1. Ah Receptor concentrations and cytochrome Pl-450 monooxygenase activities in strains of human thymic epithelial
cells in culture.
7-Ethoxycoumarin 0-deethylase, 7-Ethoxyresorufin O-deethylase,
pmole/min*mg proteina pmole/minmg proteina Human thymic Ah receptor,eamnbTatnb
epithelium strain fmole/mg Treatmentb Treatmentb
(donor's age, sex) proteinc DMSO DCDD TCDD DMSO DCDD TCDD
C 16.2 ± 1.6 0.160 ± 0.005 0.294 ± 0.020 4.902 ± 0.109*t 0.111 ± 0.006 0.312 ± 0.020* 1.585 ± 0.020*t
(16 years, female)
D 28.3 ± 3.3 0.120 ± 0.025 0.263 ± 0.004* 0.443 ± 0.035*t 0.146 ± 0.033 0.443 ± 0.031d 0.840 ± 0.014*t
(9 months, male)
H 15.2 ± 1.1 0.139 ± 0.009 0.233 ± 0.014 656 ± 0.083*t 0.066 ± 0.006 0.093 ± 0.010 0.138 ± 0.009*t
(2 months, male)
K 22.4 ± 2.5 0.179 ± 0.003 0.237 ± 0.029 0.593 ± 0.114*t 0.025 ± 0.006 0.024 ± 0.004 0.067 ± 0.017
(3.5 years, male)
L 48.8 ± 0.4 0.091 ± 0.021 0.093 ± 0.021 0.292 ± 0.046*t 0.045 ± 0.007 0.068 ± 0.002 0.121 ± 0.001*
(2 years, male)
M 18.6 ± 0.3 0.084 ± 0.001 0.150 ± 0.003* 0.231 ± 0.009*t 0.104 ± 0.010 0.119 ± 0.006 0.129 ± 0.003
(5 years, male)
N 10.9 ± 0.1 0.060 ± 0.018 0.188 ± 0.072 24.926 ± 0.477*t 0.227 ± 0.002 0.225 ± 0.022 4.701 ± 0.088*t
(4 years, female)
0 6.5 ± 0.5 0.085 ± 0.017 0.165 ± 0.006 1.072 ± 0.061*t 0.100 ± 0.018 0.105 ± 0.003 0.271 ± 0.005*t
(13 years, female)
P 8.7 ± 0.1 0.131 ± 0.008 0.552 ± 0.036 6.497 ± 0.482*t 0.065 ± 0.010 0.115 ± 0.007 0.778 ± 0.045*t
(6 years, male)
Abbreviations used: DMSO, dimethyl sulfoxide; DCDD, 2,7-dichlorodibenzo-p-dioxin; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin.
aValues are expressed as the mean ± SE ofthree experiments.
bHuman thymic epithelium was treated for 3 days with either 0.1% DMSO, 1 x 106M DCDD, or 1 x 10-8M TCDD.
'Values are expressed as the mean ± SE of two or three determinations. Cytosol was incubated with ligand for 2 hr at 20°C.
*Significantly different from control value (p <0.01).
tSignificantly different from DCDD (p <0.01).
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FIGURE 3. Con A- and PHA-dependent mitogenic responses of hu-
man thymocytes cocultured on HuTE monolayers. Each bar rep-
resents the mean ± SEM of four determinations. Asterisks in-
dicate significant difference (p < 0.01) from the control cells (thy-
mocytes cocultured on DMSO-treated TE monolayers). The
hatched bars represent thymocytes not cocultured on HuTE mon-
olayers. From Cook et al. (21).
biochemical and toxic responses; however, until re-
cently, little was known about specific transductional
mechanisms. Studies by Jones et al. (35-37) have re-
sulted in significant advances in understanding the mo-
lecular mechanisms of the TCDD-dependent induction
of cytochrome P1-450 in murine hepatoma lines. These
investigators have identified, cloned, and mapped the
upstream regulatory elements for the cytochrome P1-
450 structural gene. These elements consist of a pro-
moter (the binding site for the RNA polymerase com-
plex), an inhibitory domain that blocks promoter func-
tion, and at least two dioxin-responsive elements, the
putative nuclear acceptor sites for TCDD-Ah receptor
5' DRE DRE i P PI-450 3'
I I I I I I
Ah
5 X 3' Receptor Growth & ~ § I + Modulation V Differentiation
FIGURE 4. Proposed model for the regulation ofmultiple responses
by the Ah receptor. DRE, dioxin-responsive regulatory elements
(putative TCDD-Ah receptor DNA binding sites); i, inhibitory
domain; P, RNA polymerase binding site; X, growth regulatory
gene controlled by the TCDD-Ah receptor complex. Taken in part
from Jones et al. (36).
complexes (35) (Fig. 4). The dioxin-responsive elements
are located more than 1500 base pairs upstream from
the cytochrome P1-450 promoter (35), have the prop-
erties of transcriptional enhancers (36), and maintain
responsiveness to TCDD when transfected into either
heterologous murine tissue or a human mammary epi-
thelial cell line (36,37).
Qualitatively similarobservations havebeenreported
for the regulatory region for the cytochrome P1-450
gene isolated from C57BL/6 mouse liver (38). Dioxin
responsive elements regulating the TCDD-dependent
expression ofthe rat cytochrome P-450c gene also have
been identified (39). Jaiswal et al. (40) compared the
nucleotide sequences of the human and murine cyto-
chrome Pl-450 genes and found four highly homologous
boxes between these genes in the TATA box promoter
region. Theseobservations suggestasimilarmechanism
for the TCDD-dependent regulation of cytochilome P1-
450 gene expression in both rodent and human cells.
Based largely on studies carried out in murine skin
(14), it has been postulated that TCDD-induced alter-
ations in epithelial growth and differentiation are the
consequence of the Ah receptor-dependent regulation
of a second gene battery encoding growth regulatory
proteins (2,13). Thus, the TCDD-dependent regulation
of these genes would represent the primary response
(or signal transduction event) resulting in epithelial
growth dysfunction. Preliminary findings in this labo-
ratory suggest that TCDD-dependent adverse growth
patterns in cultured human keratinocytes require gene
transcription. Studies in progress are focused on the
identification and cloning of the putative dioxin-re-
sponse growth controlgene(s). Elucidation ofthe mech-
anisms of TCDD toxicity in the human epithelial cell
culturemodels established inthisand otherlaboratories
should further understanding ofthe cellular and molec-
ulardeterminants ofhuman susceptibility tothe HACs.
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